Dr. Reddy’s Laboratories Ltd ADR (RDY)

Dr. Reddy's Laboratories Ltd ADR (NYSE: RDY) is a global pharmaceutical company that operates in three main segments: Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others. The company manufactures and markets prescription and over-the-counter pharmaceutical products under various brand names worldwide.

The Global Generics segment is involved in manufacturing and selling both branded and generic pharmaceutical products with therapeutic equivalence. They also have a biologics business within this segment.

The PSAI segment focuses on manufacturing active pharmaceutical ingredients and intermediates that are key components of finished pharmaceutical products. They offer contract research services and cater to specific customer requirements for manufacturing active pharmaceutical ingredients and steroids.

In addition to these segments, the Others segment of Dr. Reddy's Laboratories is dedicated to developing therapies in areas like oncology and inflammation, as well as researching and developing differentiated formulations. They also provide digital healthcare services and IT-enabled business support.

The company's therapeutic categories cover a wide range including gastro-intestinal, cardiovascular, anti-diabetic, dermatology, oncology, respiratory, stomatology, urology, and nephrology. Dr. Reddy's Laboratories Limited has been in operation since 1984 and is headquartered in Hyderabad, India. To learn more, you can visit their website at https://www.drreddys.com.